lubiprostone has been researched along with Diarrhea in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 6 (46.15) | 2.80 |
| Authors | Studies |
|---|---|
| Kanzo, T; Kimura, T; Kiuchi, M; Nagazumi, A; Ohbayashi, H; Sato, Y | 1 |
| Ballou, S; Camilleri, M; Lembo, A; Rangan, V; Shin, A | 1 |
| Higurashi, T; Honda, Y; Imajo, K; Iwaki, M; Kato, S; Kato, T; Kessoku, T; Kirikoshi, H; Kobayashi, N; Kobayashi, T; Kubota, K; Nakajima, A; Ogawa, Y; Ozaki, A; Saito, S; Taguri, M; Tomeno, W; Usuda, H; Wada, K; Yamanaka, T; Yoneda, M | 1 |
| Esumi, S; Kajizono, M; Kitamura, Y; Sada, H; Sendo, T; Ushio, S | 1 |
| Asano, T; Kimura, T; Kiuchi, M; Nagazumi, A; Ohbayashi, H; Sato, Y | 1 |
| Clifford, R; Hussain, SZ; Labrum, B; Mareya, S; Stripling, S | 1 |
| Ueno, R | 1 |
| Jentsch, TJ | 1 |
| Wood, JD | 1 |
| Ford, AC; Suares, NC | 1 |
| Chong, K; Kim, S; Lembo, A; Pimentel, M; Shah, E | 1 |
| Winpenny, JP | 1 |
| Crowell, MD; DiBaise, JK; Harris, LA; Olden, KW | 1 |
5 review(s) available for lubiprostone and Diarrhea
| Article | Year |
|---|---|
Enteric nervous system: sensory physiology, diarrhea and constipation.
Topics: Alprostadil; Animals; Chloride Channels; Constipation; Cystic Fibrosis Transmembrane Conductance Regulator; Diarrhea; Enteric Nervous System; Humans; Intestinal Mucosa; Lubiprostone; Male; Mechanoreceptors; Membrane Potentials; Mice; Receptors, Prostaglandin E; Sensitivity and Specificity | 2010 |
Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis.
Topics: Alprostadil; Benzofurans; Chronic Disease; Constipation; Diarrhea; Humans; Laxatives; Lubiprostone; Peptides; Randomized Controlled Trials as Topic; Treatment Outcome | 2011 |
Evaluation of harm in the pharmacotherapy of irritable bowel syndrome.
Topics: Alprostadil; Antidepressive Agents, Tricyclic; Carbolines; Constipation; Diarrhea; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Lubiprostone; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin; Serotonin Agents | 2012 |
Lubiprostone.
Topics: Alprostadil; Constipation; Diarrhea; Fatty Acids; Headache; Humans; Lubiprostone; Nausea; Randomized Controlled Trials as Topic | 2005 |
Activation of type-2 chloride channels: a novel therapeutic target for the treatment of chronic constipation.
Topics: Alprostadil; Chloride Channel Agonists; Chloride Channels; Chronic Disease; CLC-2 Chloride Channels; Constipation; Diarrhea; Fatty Acids; Humans; Lubiprostone; Models, Biological; Nausea; Randomized Controlled Trials as Topic; Treatment Outcome | 2007 |
2 trial(s) available for lubiprostone and Diarrhea
| Article | Year |
|---|---|
Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial.
Topics: Alanine Transaminase; Constipation; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Elasticity Imaging Techniques; Female; Humans; Laxatives; Liver; Liver Function Tests; Lubiprostone; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Treatment Outcome | 2020 |
Safety of Lubiprostone in Pediatric Patients With Functional Constipation: A Nonrandomized, Open-Label Trial.
Topics: Adolescent; Adult; Alprostadil; Child; Constipation; Diarrhea; Humans; Lubiprostone; Treatment Outcome; Vomiting | 2021 |
6 other study(ies) available for lubiprostone and Diarrhea
| Article | Year |
|---|---|
Analysis of the impact on efficacy of lubiprostone dose reduction to manage adverse events in the treatment of chronic constipation in Japan.
Topics: Alprostadil; Constipation; Diarrhea; Double-Blind Method; Drug Tapering; Humans; Japan; Lubiprostone; Nausea; Treatment Outcome | 2022 |
Use of Treatments for Irritable Bowel Syndrome and Patient Satisfaction Based on the IBS in America Survey.
Topics: Attitude of Health Personnel; Constipation; Diarrhea; Diet; Dietary Fiber; Dietary Supplements; Dioctyl Sulfosuccinic Acid; Female; Gastrointestinal Agents; Health Care Surveys; Humans; Irritable Bowel Syndrome; Laxatives; Lubiprostone; Male; Middle Aged; Parasympatholytics; Patient Satisfaction; Probiotics; Rifaximin | 2020 |
The Efficacy and Safety of Lubiprostone for Constipation in Cancer Patients Compared with Non-cancer Patients: A Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Constipation; Defecation; Diarrhea; Female; Humans; Incidence; Lubiprostone; Male; Middle Aged; Nausea; Neoplasms; Retrospective Studies; Treatment Outcome | 2020 |
Open-label study to evaluate the treatment continuation rate after a dose reduction of lubiprostone due to onset of adverse events.
Topics: Adult; Aged; Chloride Channel Agonists; Chronic Disease; Constipation; Diarrhea; Drug Tapering; Female; Humans; Lubiprostone; Male; Middle Aged; Nausea; Vomiting; Withholding Treatment | 2021 |
To the editor. CLC chloride channels and transporters: from genes to protein structure, pathology and physiology.
Topics: Alprostadil; Cell Line; Chloride Channels; Constipation; Diarrhea; Humans; Lubiprostone | 2009 |
To the editor. CLC chloride channels and transporters: from genes to protein structure, pathology and physiology.
Topics: Alprostadil; Chloride Channels; Clinical Trials as Topic; Constipation; Diarrhea; Humans; Lubiprostone | 2009 |